Effect of exercise training in patients with cardiac sarcoidosis after induction of oral corticosteroid therapy.

Hidetoshi Yanagi, Harumi Konishi, Yukihiro Shimada, Hiroyuki Miura, Tatsuo Aoki, Teruo Noguchi
{"title":"Effect of exercise training in patients with cardiac sarcoidosis after induction of oral corticosteroid therapy.","authors":"Hidetoshi Yanagi, Harumi Konishi, Yukihiro Shimada, Hiroyuki Miura, Tatsuo Aoki, Teruo Noguchi","doi":"10.36141/svdld.v42i3.15628","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>To our knowledge, no study has investigated altered muscle strength in patients with cardiac sarcoidosis (CS). This retrospective observational study investigated the relationship between quadriceps isometric strength (QIS) and exercise training (ET) in patients with CS.</p><p><strong>Methods: </strong>Eighteen patients who participated in a 4-month ET programme immediately after initiating oral corticosteroids were studied. They underwent 3-5 ET sessions per week during hospitalisation and 1-2 sessions per week after discharge. We measured their QIS at the beginning of the ET programme and at 1 and 4 months after programme enrolment. The patients received 29±4 mg/day prednisolone during the corticosteroid induction period and 15±4 mg/day prednisolone during the corticosteroid tapering period.</p><p><strong>Results: </strong>They continued ET and showed significant QIS weakness in the early corticosteroid induction period (0.52±0.12 to 0.48±0.11 kgf/kg, P=.048) and no significant improvement during the corticosteroid tapering period (0.53±0.08 to 0.58±0.06 kgf/kg, P=.099). Patients who received ≤12.5 mg/day prednisolone reported an improved QIS-to-body weight ratio.</p><p><strong>Conclusions: </strong>Patients with CS treated with 30 mg/day prednisolone showed poor QIS early in the corticosteroid induction period, even with ET. Patients with CS who receive corticosteroids may be more susceptible to developing corticosteroid myopathy.</p>","PeriodicalId":502142,"journal":{"name":"Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG","volume":"42 3","pages":"15628"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536840/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36141/svdld.v42i3.15628","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: To our knowledge, no study has investigated altered muscle strength in patients with cardiac sarcoidosis (CS). This retrospective observational study investigated the relationship between quadriceps isometric strength (QIS) and exercise training (ET) in patients with CS.

Methods: Eighteen patients who participated in a 4-month ET programme immediately after initiating oral corticosteroids were studied. They underwent 3-5 ET sessions per week during hospitalisation and 1-2 sessions per week after discharge. We measured their QIS at the beginning of the ET programme and at 1 and 4 months after programme enrolment. The patients received 29±4 mg/day prednisolone during the corticosteroid induction period and 15±4 mg/day prednisolone during the corticosteroid tapering period.

Results: They continued ET and showed significant QIS weakness in the early corticosteroid induction period (0.52±0.12 to 0.48±0.11 kgf/kg, P=.048) and no significant improvement during the corticosteroid tapering period (0.53±0.08 to 0.58±0.06 kgf/kg, P=.099). Patients who received ≤12.5 mg/day prednisolone reported an improved QIS-to-body weight ratio.

Conclusions: Patients with CS treated with 30 mg/day prednisolone showed poor QIS early in the corticosteroid induction period, even with ET. Patients with CS who receive corticosteroids may be more susceptible to developing corticosteroid myopathy.

Abstract Image

Abstract Image

运动训练对心脏结节病患者口服皮质类固醇治疗诱导后的影响。
背景和目的:据我们所知,没有研究调查心脏结节病(CS)患者肌肉力量的改变。这项回顾性观察性研究调查了CS患者四头肌等长力量(QIS)和运动训练(ET)之间的关系。方法:对18例口服皮质类固醇后立即进行4个月ET治疗的患者进行研究。他们住院期间每周接受3-5次ET治疗,出院后每周接受1-2次ET治疗。我们在ET项目开始时以及项目注册后1个月和4个月测量了他们的QIS。患者在皮质类固醇诱导期接受29±4 mg/天的强的松龙治疗,在皮质类固醇减量期接受15±4 mg/天的强的松龙治疗。结果:患者在激素诱导期(0.52±0.12 ~ 0.48±0.11 kgf/kg, P= 0.048)持续ET, QIS明显减弱,在激素减量期(0.53±0.08 ~ 0.58±0.06 kgf/kg, P= 0.099)无明显改善。接受≤12.5 mg/天强的松龙治疗的患者报告了qis -体重比的改善。结论:接受30 mg/d泼尼松龙治疗的CS患者在皮质类固醇诱导期早期QIS较差,即使有ET。接受皮质类固醇治疗的CS患者可能更容易发生皮质类固醇肌病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书